Find Elobixibat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 439087-18-0, Azd7806, Azd-7806, 865uek4ejc, A-3309, Glycine, (2r)-n-(2-((3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl)oxy)acetyl)-2-phenylglycyl-
Molecular Formula
C36H45N3O7S2
Molecular Weight
695.9  g/mol
InChI Key
XFLQIRAKKLNXRQ-UUWRZZSWSA-N
FDA UNII
865UEK4EJC

Elobixibat
Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.
1 2D Structure

Elobixibat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-16,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid
2.1.2 InChI
InChI=1S/C36H45N3O7S2/c1-4-6-18-36(19-7-5-2)24-39(27-16-12-9-13-17-27)28-20-30(47-3)29(21-31(28)48(44,45)25-36)46-23-32(40)38-34(26-14-10-8-11-15-26)35(43)37-22-33(41)42/h8-17,20-21,34H,4-7,18-19,22-25H2,1-3H3,(H,37,43)(H,38,40)(H,41,42)/t34-/m1/s1
2.1.3 InChI Key
XFLQIRAKKLNXRQ-UUWRZZSWSA-N
2.1.4 Canonical SMILES
CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)NC(C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC
2.1.5 Isomeric SMILES
CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)N[C@H](C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC
2.2 Other Identifiers
2.2.1 UNII
865UEK4EJC
2.3 Synonyms
2.3.1 MeSH Synonyms

1. A3309

2.3.2 Depositor-Supplied Synonyms

1. 439087-18-0

2. Azd7806

3. Azd-7806

4. 865uek4ejc

5. A-3309

6. Glycine, (2r)-n-(2-((3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl)oxy)acetyl)-2-phenylglycyl-

7. Goofice

8. (r)-(2-(2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetyl)glycine

9. 2-[[(2r)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1lambda6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic Acid

10. Elobixibat [inn]

11. Azd 7806

12. Elobixibat [usan:inn]

13. Unii-865uek4ejc

14. Ajg533

15. Elobixibat [mi]

16. Elobixibat (usan/inn)

17. Elobixibat [usan]

18. A 3309

19. Elobixibat [who-dd]

20. Gtpl9996

21. Schembl1183501

22. Chembl3039515

23. Bdbm77088

24. Dtxsid00195985

25. Ex-a5983

26. Db12486

27. Hy-15790

28. Cs-0009139

29. J3.548.450g

30. D10796

31. Us9694018, 14

32. Q5367035

33. ((2r)-2-(2-((3,3-dibutyl-7-(methylsulfanyl)-1,1-dioxo-5-phenyl-2,3,4,5-tetrahydro-1h-1.lambda.6,5-benzothiazepin-8-yl)oxy)acetamido)-2-phenylacetamido)acetic Acid

34. 2-[[(2r)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydrobenzo[b][1,4]thiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic Acid

35. Glycine, (2r)-n-(((3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl)oxy)acetyl)-2-phenylglycyl-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 695.9 g/mol
Molecular Formula C36H45N3O7S2
XLogP37.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count16
Exact Mass695.26989313 g/mol
Monoisotopic Mass695.26989313 g/mol
Topological Polar Surface Area176 Ų
Heavy Atom Count48
Formal Charge0
Complexity1140
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of chronic constipation


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"ELOBIXIBAT","year":"2021","qtr":"Q1","strtotime":1610994600,"product":"ELOBIXIBAT IH","address":"FLAT NO.302, BHANU ENCLAVESUNDER NAGAR ,ERRAGADDA","city":"HYDERABAD.AP","supplier":"METROCHEM API PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"AL ANDALOUS FOR ","customerCountry":"EGYPT","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"38.5","totalValueFC":"5844.3","currency":"USD","unitRateINR":2849.5533333333333,"date":"19-Jan-2021","totalValueINR":"427433","totalValueInUsd":"5844.3","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"8001794","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"FLAT NO.302, BHANU ENCLAVESUNDER NAGAR ,ERRAGADDA, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658255400,"product":"ELOBIXIBAT MONOHYDRATE","address":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3","city":"","supplier":"SYNGENE INTERNATIONAL LIMITED","supplierCountry":"INDIA","foreign_port":"NARITA APT\/TOKYO","customer":"EA PHARMA","customerCountry":"JAPAN","quantity":"104.00","actualQuantity":"104","unit":"KGS","unitRateFc":"4710.3","totalValueFC":"481764.2","currency":"USD","unitRateINR":368348.31730769231,"date":"20-Jul-2022","totalValueINR":"38308225","totalValueInUsd":"481764.2","indian_port":"Biocon-SEZ","hs_no":"29420090","bill_no":"4003594","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Biocon-SEZ","supplierAddress":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661106600,"product":"ELOBIXIBAT HYDRATE","address":"7-1-638 TO 643, 643\/1,FLAT NO. 302 ,,BHANU ENCLAVE, ERRAGADDA","city":"HYDERABAD,TELANGANA","supplier":"METROCHEM API PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"ALESRAA PHARMACEUTICAL OPTIMA","customerCountry":"EGYPT","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"40000","totalValueFC":"3933.8","currency":"USD","unitRateINR":3130000,"date":"22-Aug-2022","totalValueINR":"313000","totalValueInUsd":"3933.8","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"3645984","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-1-638 TO 643, 643\/1,FLAT NO. 302 ,,BHANU ENCLAVE, ERRAGADDA, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687717800,"product":"ELOBIXIBAT MONOHYDRATE","address":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3","city":"","supplier":"SYNGENE INTERNATIONAL LIMITED","supplierCountry":"INDIA","foreign_port":"NARITA APT\/TOKYO","customer":"EA PHARMA CO. ","customerCountry":"JAPAN","quantity":"104.00","actualQuantity":"104","unit":"KGS","unitRateFc":"4534.3","totalValueFC":"466715.2","currency":"USD","unitRateINR":368867.85576923075,"date":"26-Jun-2023","totalValueINR":"38362257","totalValueInUsd":"466715.2","indian_port":"Biocon-SEZ","hs_no":"29420090","bill_no":"4003503","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Biocon-SEZ","supplierAddress":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711045800,"product":"ELOBIXIBAT MONOHYDRATE","address":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3","city":"","supplier":"SYNGENE INTERNATIONAL LIMITED","supplierCountry":"INDIA","foreign_port":"TOKYO","customer":"EA PHARMA CO. ","customerCountry":"JAPAN","quantity":"159.00","actualQuantity":"159","unit":"KGS","unitRateFc":"6112.3","totalValueFC":"962065.4","currency":"USD","unitRateINR":502426.77987421385,"date":"22-Mar-2024","totalValueINR":"79885858","totalValueInUsd":"962065.4","indian_port":"Biocon-SEZ","hs_no":"29420090","bill_no":"4001484","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Biocon-SEZ","supplierAddress":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724783400,"product":"FINE ORGANIC COMPOUNDSELOBIXIBAT MONOHYDRATE","address":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3","city":"N\/A","supplier":"SYNGENE INTERNATIONAL LIMITED","supplierCountry":"INDIA","foreign_port":"TOKYO","customer":"EA PHARMA CO ","customerCountry":"JAPAN","quantity":"156.48","actualQuantity":"156.48","unit":"KGS","unitRateFc":"6126","totalValueFC":"949699","currency":"USD","unitRateINR":509070.60001278116,"date":"28-Aug-2024","totalValueINR":"79659367.49","totalValueInUsd":"949699","indian_port":"Biocon-SEZ","hs_no":"29420090","bill_no":"3536516","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Biocon-SEZ","supplierAddress":"BIOCON SEZ, BIOCON PARK,PLOT NO.2 3, N\/A","customerAddress":""}]
19-Jan-2021
28-Aug-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty